Molecular Testing for MRSA and C. diff.: Using New Tools to Identify and Reduce HAIs
15 Nov 2012

For both economic and regulatory reasons, hospitals and other healthcare facilities are stepping up efforts to decrease healthcare-associated infection (HAI) rates. Clinical labs can be helpful in these initiatives, particularly in identifying methicillin-resistant Staphylococcus aureus (MRSA) and Clostridium difficile (C. diff.) infections. This webinar discusses the new technologies that detect these pathogens more quickly and accurately than ever before, and how labs are incorporating them into their testing strategies and surveillance programs.

AACC



Show    per page
1 of 9 Page     1 2 3  ... Next 
Characterization of Glycoproteins: 25 Years of HPAEC-PAD Analysis28 Oct 2014Read
Validation of the TruSight One Sequencing Panel for Clinical Research16 Oct 2014Read
Ion Mobility Derived Collision Cross Sections to Support Metabolomics and Lipidomics15 Oct 2014Read
Non-targeted and Targeted Analysis of Anionic Metabolites Using Ion Chromatography and High Resolution Accurate Mass Spectrometry1 Oct 2014Read
A new approach to improving early characterization of therapeutic formulations - Viscosizer 2005 Sep 2014Read
An introduction to capillary rheometry - Evaluating material properties under process relevant conditions5 Sep 2014Read
Speed your way though your protein formulation screening by automating your measurements5 Sep 2014Read
Novel analytical technologies for product deformulation - Part 25 Sep 2014Read
Water treatment - Optimize coagulant dosing using zeta potential5 Sep 2014Read
Applications of rheology in the waxes, creams and emulsions arena5 Sep 2014Read